[Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution]
- PMID: 6227542
[Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution]
Abstract
Efficacy and tolerance of an alcoholic solution containing 0.64 mg betamethasone-dipropionate plus 20 mg salicylic acid (Diprosalic Solution) were compared with an alcoholic solution containing 0,64 mg betamethasone-dipropionate in a 3 week double blind study in 100 patients with psoriasis and other steroid-responsive dermatoses of dry nature, comprising scalp and other hairy and non-hairy areas of the body. This double blind study was followed by a 3 week open study in another 100 patients with similar diagnosis, using Diprosalic Solution only. Although the therapeutic results of the double blind study showed no significant differences between both treatment groups, distinct advantages of the drug containing salicylic acid could be clearly demonstrated, such as: 1. More rapid onset of action, 2. rapid clearing of scaling, pruritus and inflammation, 3. these advantages are in compliance with the fact that topically applied salicylic acid softens keratin, loosens cornified epithelium and desquamates the epidermis, making the underlying layers more accessible to the antiinflammatory steroid.
Similar articles
-
Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.Indian J Dermatol. 1987 Apr;32(2):41-4. Indian J Dermatol. 1987. PMID: 3453353 No abstract available.
-
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.Clin Ther. 1983;5(3):290-8. Clin Ther. 1983. PMID: 6850723
-
Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').Pharmatherapeutica. 1981;3(1):61-6. Pharmatherapeutica. 1981. PMID: 7033993 Clinical Trial.
-
Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.Skin Therapy Lett. 2002 Jun;7(6):1-3. Skin Therapy Lett. 2002. PMID: 12223976 Review.
-
DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis.Expert Rev Clin Immunol. 2017 Feb;13(2):85-91. doi: 10.1080/1744666X.2017.1270756. Epub 2016 Dec 21. Expert Rev Clin Immunol. 2017. PMID: 27967262 Review.
Cited by
-
Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review.Dermatol Ther (Heidelb). 2015 Mar;5(1):1-18. doi: 10.1007/s13555-015-0068-3. Epub 2015 Jan 21. Dermatol Ther (Heidelb). 2015. PMID: 25604924 Free PMC article.
-
Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp.Cochrane Database Syst Rev. 2014 May 19;2014(5):CD009446. doi: 10.1002/14651858.CD009446.pub2. Cochrane Database Syst Rev. 2014. PMID: 24838779 Free PMC article.
-
Topical treatments for scalp psoriasis.Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD009687. doi: 10.1002/14651858.CD009687.pub2. Cochrane Database Syst Rev. 2016. PMID: 26915340 Free PMC article.